← Back
Data updated: Mar 29, 2026
I3 PHARMS
Cardiovascular
Specialty
I3 PHARMS is a specialty pharmaceutical company focused on Cardiovascular.
1973
Since
5
Drugs
-
Trials
3
Approved (2yr)
Top Drug Revenues Pro
Loading...
Revenue Over Time Pro
Loading...
Recent Activity
SEC Filings
Pro
Loading...
Therapeutic Areas
Score weights: Approved drugs ×3, Phase 3 ×2, Phase 2 ×1, Phase 1 ×0.5
Cardiovascular 100%
2 drugs
Pipeline Forecast
Loading...
Loading...
Upcoming Trial Milestones Pro
Loading...
Patent Cliff Pro
Loading...
Loading...
Loading...
Discontinued (2)
Company Info
- First Approval
- 1973-11-27
- Latest
- 2024-01-30
- Applications
- 5